PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Rescue of Alzheimer's memory deficit achieved by reducing 'excessive inhibition'

Rescue of Alzheimer's memory deficit achieved by reducing 'excessive inhibition'
2014-06-13
(Press-News.org) A new drug target to fight Alzheimer's disease has been discovered by a research team led by Gong Chen, a Professor of Biology and the Verne M. Willaman Chair in Life Sciences at Penn State University. The discovery also has potential for development as a novel diagnostic tool for Alzheimer's disease, which is the most common form of dementia and one for which no cure has yet been found. A scientific paper describing the discovery will be published in Nature Communications on 13 June 2014.

Chen's research was motivated by the recent failure in clinical trials of once-promising Alzheimer's drugs being developed by large pharmaceutical companies. "Billions of dollars were invested in years of research leading up to the clinical trials of those Alzheimer's drugs, but they failed the test after they unexpectedly worsened the patients' symptoms," Chen said. The research behind those drugs had targeted the long-recognized feature of Alzheimer's brains: the sticky buildup of the amyloid protein known as plaques, which can cause neurons in the brain to die. "The research of our lab and others now has focused on finding new drug targets and on developing new approaches for diagnosing and treating Alzheimer's disease," Chen explained.

"We recently discovered an abnormally high concentration of one inhibitory neurotransmitter in the brains of deceased Alzheimer's patients," Chen said. He and his research team found the neurotransmitter, called GABA (gamma-aminobutyric acid), in deformed cells called "reactive astrocytes" in a structure in the core of the brain called the dentate gyrus. This structure is the gateway to hippocampus, an area of the brain that is critical for learning and memory.

Chen's team found that the GABA neurotransmitter was drastically increased in the deformed versions of the normally large, star-shaped "astrocyte" cells which, in a healthy individual, surround and support individual neurons in the brain. "Our research shows that the excessively high concentration of the GABA neurotransmitter in these reactive astrocytes is a novel biomarker that we hope can be targeted in further research as a tool for the diagnosis and treatment of Alzheimer's disease," Chen said.

Chen's team developed new analysis methods to evaluate neurotransmitter concentrations in the brains of normal and genetically modified mouse models for Alzheimer's disease (AD mice). "Our studies of AD mice showed that the high concentration of the GABA neurotransmitter in the reactive astrocytes of the dentate gyrus correlates with the animals' poor performance on tests of learning and memory," Chen said. His lab also found that the high concentration of the GABA neurotransmitter in the reactive astrocytes is released through an astrocyte-specific GABA transporter, a novel drug target found in this study, to enhance GABA inhibition in the dentate gyrus. With too much inhibitory GABA neurotransmitter, the neurons in the dentate gyrus are not fired up like they normally would be when a healthy person is learning something new or remembering something already learned.

Importantly, Chen said, "After we inhibited the astrocytic GABA transporter to reduce GABA inhibition in the brains of the AD mice, we found that they showed better memory capability than the control AD mice. We are very excited and encouraged by this result, because it might explain why previous clinical trials failed by targeting amyloid plaques alone. One possible explanation is that while amyloid plaques may be reduced by targeting amyloid proteins, the other downstream alterations triggered by amyloid deposits, such as the excessive GABA inhibition discovered in our study, cannot be corrected by targeting amyloid proteins alone. Our studies suggest that reducing the excessive GABA inhibition to the neurons in the brain's dentate gyrus may lead to a novel therapy for Alzheimer's disease. An ultimate successful therapy may be a cocktail of compounds acting on several drug targets simultaneously."

INFORMATION: EMBARGOED: Publication of information about the research described here is prohibited -- in any medium -- by the journal Nature Communications until 5:00 a.m., U. S. Eastern time DST / 1000 London time BS, on 13 June 2014.

In addition to Chen, other members of the research team include Postdoctoral Scholar Zheng Wu and Graduate Researcher Ziyuan Guo at Penn State, and Marla Gearing at Emory University.

This research received support from the National Institutes of Health and Penn State University's Eberly College of Science Stem Cell Fund.

[ Barbara K. Kennedy ]

CONTACTS Gong Chen: gongchen@psu.edu Barbara Kennedy (PIO): science@psu.edu, (+1) 814 863 4682

IMAGES A high-resolution image is online at http://science.psu.edu/news-and-events/2014-news/Chen6-2014

[Attachments] See images for this press release:
Rescue of Alzheimer's memory deficit achieved by reducing 'excessive inhibition'

ELSE PRESS RELEASES FROM THIS DATE:

Genotyping can predict disease outcomes in rheumatoid arthritis patients

2014-06-13
New cohort studies presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) have shown the amino acid valine at position 11 of HLA-DRB1 gene to be the strongest independent genetic determinant of radiological damage in rheumatoid arthritis (RA).1 In addition, positions 71 and 74 were found to represent independent predictors, with the three positions together: 11, 71 and 74 strongly associated with disease outcomes.1 According to lead author Dr Sebastien Viatte of the Arthritis Research UK Centre for Genetics and Genomics, Manchester, United ...

Higher health care cost burden of musculoskeletal conditions compared to other diseases

2014-06-13
A new study presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) highlights the increased health care costs associated with musculoskeletal conditions compared to other diseases. Health care costs were almost 50% higher for people with a musculoskeletal condition compared to any other singly occurring condition.1 This disparity remained high where two conditions co-existed, with health care costs still one third higher (36%) for those people with one of their two conditions musculoskeletal in nature, highlighting the significant impact ...

Sjögren's Syndrome significantly increases risk of heart attack

2014-06-13
A new study presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed a significantly increased risk of heart attack in patients with Sjögren's syndrome (SjS), particularly in the first year following diagnosis. There was also a trend towards an increased risk for stroke. SjS is an auto-immune inflammatory disease where the body's immune system attacks glands that secrete fluid, such as the tear and saliva glands.2 Inflammation within the glands reduces fluid production causing painful burning in the eyes, dry mouth, and sometimes dryness ...

Biomarkers predict long-term outcomes in juvenile idiopathic arthritis

2014-06-13
Data presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) demonstrate the possibility of using biomarkers (developed from whole blood gene expression profiles) in children with juvenile idiopathic arthritis (JIA) to predict the status of their disease at 12 months. The long-term disease status at 12 months was accurately predicted only after treatment had been initiated, in newly diagnosed patients.1 JIA is the most common childhood* chronic rheumatic disease,2 affecting 16-150 children in every 100,000. As indicated by the name, the ...

Tamoxifen-resistant breast cancer reversed when drug paired with anti-malaria agent

2014-06-13
WASHINGTON — The inexpensive anti-malarial drug hydroxychloroquine (HCQ) reverses resistance to tamoxifen, a widely used breast cancer drug, in mice. In the June 15 issue of Clinical Cancer Research, investigators from Georgetown Lombardi Comprehensive Cancer Center say adding HCQ to tamoxifen could provide a new treatment option for some women with advanced, postmenopausal estrogen receptor-positive (ER+) breast cancer. The ER+ subtype accounts for an estimated 70 percent of all breast cancers. While many of these women are treated with tamoxifen, which blocks estrogen ...

New research shows Western Amazon under threat from oil pollution

2014-06-13
A new study of pollution records indicates that the Western Amazon, an area of unparalleled biological and cultural diversity, may have been contaminated by widespread oil pollution over a 30-year period. This work will be presented at the Goldschmidt conference in Sacramento, California Most of the world's tropical rainforests contain oil and gas reserves. Oil production started in the Western Amazon in the 1920s and peaked in the 1970s, but current growing global demand is stimulating a renewed growth in oil and gas extraction. Nearly 70% of the Peruvian Amazon was ...

Study shows gut microbe composition different in young children with and without type 1 diabetes

2014-06-13
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that children diagnosed with type 1 diabetes have a less balanced composition of gut bacteria compared with children of the same age without diabetes. The research is by Dr Marcus de Goffau and Dr Hermie Harmsen, University Medical Center Groningen, the Netherlands, and colleagues. The incidence of type 1 diabetes is increasing worldwide, showing a particularly sharp increase among children under the age of 5 years. Recent studies indicate that adverse changes ...

Smartphone apps carry higher infection risk than online dating sites or clubs

2014-06-13
Phone dating apps used by gay men to find a sexual partner carry a higher risk of getting common sexually transmitted infections than meeting online or in bars and clubs, suggests research published online in the journal Sexually Transmitted Infections. Previous research has suggested that gay and bi-curious men who meet online are more likely to indulge in unprotected sex and to have more partners than men meeting potential partners in other ways. But since 2009 smartphone apps, such as Grindr, Scruff, and Recon, have become an increasingly popular way to hook up with ...

Use of cement in partial hip replacement linked to risk of death

2014-06-13
The use of cement in partial hip replacement surgery may be linked to a risk of death - often occurring within minutes - finds research published in the online journal BMJ Open. The risk is relatively rare. But the alarm was first sounded in 2009, and most of the cases that have come to light have occurred since that date, say the authors, who include the former chief medical officer for England. This suggests that measures to reduce the risks are not being acted on widely enough, they say. They base their findings on an analysis of cases submitted between 2005 and ...

New test detects toxic prions in blood

2014-06-13
The first cases of Mad Cow disease in humans (properly called variant Creutzfeld Jakob Disease, or vCJD) occurred in the late 1990s and are thought to be the consequence of eating contaminated beef products. Since then, several cases of secondary infections caused by transfusions with blood from donors who subsequently developed vCJD have been reported, raising concerns about the safety of blood and blood products. A paper published in PLOS Pathogens on June 12th now describes an assay that can detect prions in blood samples from humans with vCJD and in animals at early ...

LAST 30 PRESS RELEASES:

Being physically active, even just a couple of days a week, may be key to better health

High-fat diet promote breast cancer metastasis in animal models

A router for photons

Nurses and AI collaborate to save lives, reduce hospital stays

Multi-resistance in bacteria predicted by AI model

Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

[Press-News.org] Rescue of Alzheimer's memory deficit achieved by reducing 'excessive inhibition'